We are live on
!
Find out more
MCM
Marsico Capital Management Portfolio holdings
AUM
$3.4B
1-Year Est. Return
51.58%
This Fund
S&P 500
This Quarter
Est. Return
+3.08%
1 Year Est. Return
+51.58%
3 Year Est. Return
+243.93%
5 Year Est. Return
+321.58%
10 Year Est. Return
+1,831.46%
AUM
$11.3B
AUM Growth
-$536M
(-4.5%)
Cap. Flow
-$722M
Cap. Flow
% of AUM
-6.38%
Top 10 Holdings %
Top 10 Hldgs %
44.21%
Holding
104
New
17
Increased
29
Reduced
44
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$232M |
| 2 |
Electronic Arts
EA
|
+$162M |
| 3 |
Salesforce
CRM
|
+$118M |
| 4 |
Bausch Health
BHC
|
+$90.4M |
| 5 |
Zoetis
ZTS
|
+$87.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$265M |
| 2 |
Biogen
BIIB
|
+$215M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$190M |
| 4 |
Union Pacific
UNP
|
+$158M |
| 5 |
Alibaba
BABA
|
+$148M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.72% |
| 2 | Communication Services | 19.78% |
| 3 | Technology | 14.98% |
| 4 | Consumer Discretionary | 12.37% |
| 5 | Financials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
LyondellBasell Industries
LYB
$19.2B
| $12.8M | 0.11% |
+123,647
| New | +$12.4M |
|
|
MBLY
77
DELISTED
Mobileye N.V.
MBLY
| $12.8M | 0.11% |
240,151
+59,618
| +33% | +$2.83M |
|
|
PRTY
78
DELISTED
Party City Holdco Inc.
PRTY
| $11.3M | 0.1% |
+558,805
| New | +$11.9M |
|
79
XPO
XPO
$23.5B
| $11.2M | 0.1% |
714,952
+249,322
| +54% | +$4.04M |
|
|
GMCR
80
DELISTED
KEURIG GREEN MTN INC
GMCR
| $9.6M | 0.08% |
125,232
+74,173
| +145% | +$7.28M |
|
81
IMAX
IMAX
$2.79B
| $8.94M | 0.08% |
+222,048
| New | +$8.62M |
|
82
Netflix
NFLX
$306B
| $7.19M | 0.06% |
+766,570
| New | +$6.42M |
|
83
Trip.com Group
TCOM
$29B
| $6.84M | 0.06% |
+188,510
| New | +$6.58M |
|
|
JUNO
84
DELISTED
Juno Therapeutics, Inc.
JUNO
| $5.62M | 0.05% |
105,434
-120,868
| -53% | -$6.42M |
|
|
ALPN
85
DELISTED
Alpine Immune Sciences Inc
ALPN
| $4.54M | 0.04% |
+75,000
| New | +$4.47M |
|
86
MakeMyTrip
MMYT
$5.74B
| $3.54M | 0.03% |
+179,602
| New | +$3.75M |
|
87
Vipshop
VIPS
$7.48B
| $3.31M | 0.03% |
+148,824
| New | +$3.94M |
|
|
BKI
88
DELISTED
Black Knight, Inc. Common Stock
BKI
| $3.07M | 0.03% |
+99,432
| New | +$2.87M |
|
|
DTEA
89
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
| $2.33M | 0.02% |
+108,421
| New | +$2.68M |
|
|
AAC
90
DELISTED
AAC Holdings
AAC
| $731K | 0.01% |
+16,770
| New | +$617K |
|
|
ARMH
91
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $611K | 0.01% |
12,404
-6,983
| -36% | -$363K |
|
92
Baidu
BIDU
$37.8B
| – | – |
-107,244
| Closed | -$22.4M |
|
93
Celldex Therapeutics
CLDX
$3.14B
| – | – |
-15,820
| Closed | -$6.61M |
|
|
94
Gilead Sciences
GILD
$162B
| – | – |
-2,699,926
| Closed | -$265M |
|
95
Merck
MRK
$318B
| – | – |
-2,260,712
| Closed | -$124M |
|
96
Morgan Stanley
MS
$344B
| – | – |
-639,361
| Closed | -$22.8M |
|
97
Williams-Sonoma
WSM
$29.4B
| – | – |
-36,366
| Closed | -$1.45M |
|
98
Wynn Resorts
WYNN
$10.8B
| – | – |
-652,675
| Closed | -$82.2M |
|
|
TTM
99
DELISTED
Tata Motors Limited
TTM
| – | – |
-391,974
| Closed | -$17.7M |
|
|
MON
100
DELISTED
Monsanto Co
MON
| – | – |
-781,121
| Closed | -$87.9M |
|
Similar funds
BG
OAM
DFO
VFCM
CIA
EFM
JGC
PWP
Marsico Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Marsico Capital Management held 104 positions worth $11.3B, down 4.5% from $11.9B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Marsico Capital Management withdrew a net $722M in Q2 2015, closing 13 positions and reducing 44 holdings. Its most notable exit was Gilead Sciences, an estimated $265M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Technology.
Against the trend, Marsico Capital Management opened a new position in Zoetis worth $88.2M.
- Marsico Capital Management's largest Q2 2015 buy was Zoetis: 1,828,140 shares worth $88.2M.
- Marsico Capital Management added most to Illumina in Q2 2015, an estimated $232M increase.
- Marsico Capital Management's biggest Q2 2015 reduction was Biogen, cutting an estimated $215M.
- Marsico Capital Management fully exited Gilead Sciences in Q2 2015, selling an estimated $265M.
- Marsico Capital Management's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2015.
- Marsico Capital Management opened 17 new positions and closed 13 in Q2 2015.
- Marsico Capital Management's portfolio value fell 4.5% quarter-over-quarter to $11.3B.
Based on Marsico Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.